000			02024 a2200529 4500
005			20250518013913.0
264		0	_c20190701
008			201907s 0 0 eng d
022			_a1178-2005
024	7		_a10.2147/COPD.S177097 _2doi
040			_aNLM _beng _cNLM
100	1		_aRajagopalan, Krithika
245	0	0	_aCost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US. _h[electronic resource]
260			_bInternational journal of chronic obstructive pulmonary disease _c
300			_a3867-3877 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdministration, Inhalation
650	0	4	_aAdrenergic beta-2 Receptor Agonists _xadministration & dosage
650	0	4	_aBronchodilator Agents _xadministration & dosage
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Combinations
650	0	4	_aDrug Costs
650	0	4	_aForced Expiratory Volume
650	0	4	_aGlycopyrrolate _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIndans _xadministration & dosage
650	0	4	_aLung _xdrug effects
650	0	4	_aMarkov Chains
650	0	4	_aModels, Economic
650	0	4	_aMuscarinic Antagonists _xadministration & dosage
650	0	4	_aNebulizers and Vaporizers _xeconomics
650	0	4	_aPowders
650	0	4	_aPulmonary Disease, Chronic Obstructive _xdiagnosis
650	0	4	_aQuinolones _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aSeverity of Illness Index
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
700	1		_aBloudek, Lisa
700	1		_aMarvel, Jessica
700	1		_aDembek, Carole
700	1		_aKavati, Abhishek
773	0		_tInternational journal of chronic obstructive pulmonary disease _gvol. 13 _gp. 3867-3877
856	4	0	_uhttps://doi.org/10.2147/COPD.S177097 _zAvailable from publisher's website
999			_c29181107 _d29181107